Clinical Trial Update: European Study of Cardiovascular Risk

View source ↗

Summary

A European cardiovascular risk trial sponsored by AstraZeneca has completed, focusing on cardiovascular risk factors and hyperlipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Diabetes Mellitus
• Hyperlipidemia
• Hypertension
• Obesity

Snippet

Sponsor: AstraZeneca | Conditions: Cardiovascular Risk Factors, Hyperlipidemia | Status: COMPLETED